SG59864G - 1-oxa-2-oxo-3,8-diazaspirol[4,5] decane derivatives pharmaceutical compositions containing them and processes for preparing them - Google Patents

1-oxa-2-oxo-3,8-diazaspirol[4,5] decane derivatives pharmaceutical compositions containing them and processes for preparing them

Info

Publication number
SG59864G
SG59864G SG1995903969A SG1995903969A SG59864G SG 59864 G SG59864 G SG 59864G SG 1995903969 A SG1995903969 A SG 1995903969A SG 1995903969 A SG1995903969 A SG 1995903969A SG 59864 G SG59864 G SG 59864G
Authority
SG
Singapore
Prior art keywords
alkyl
ethynyl
fluorophenyl
bis
diazaspirol
Prior art date
Application number
SG1995903969A
Other languages
English (en)
Inventor
Edit Toth
Jozsef Toerley
Sandor Dr Goeroeg
Laszio Dr Szporny
Bela Kiss
Eva Dr Palosi
Dora Dr Groo
Istvan Dr Laszlovszky
Erzsebet Dr Lapis
Ferenc Auth
Laszlo Dr Gaal
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SG59864G publication Critical patent/SG59864G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
SG1995903969A 1989-08-10 1990-08-09 1-oxa-2-oxo-3,8-diazaspirol[4,5] decane derivatives pharmaceutical compositions containing them and processes for preparing them SG59864G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894094A HU204276B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-4-methylen-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
SG59864G true SG59864G (en) 1995-09-01

Family

ID=10966866

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995903969A SG59864G (en) 1989-08-10 1990-08-09 1-oxa-2-oxo-3,8-diazaspirol[4,5] decane derivatives pharmaceutical compositions containing them and processes for preparing them

Country Status (26)

Country Link
US (2) US5132309A (sh)
EP (2) EP0412821B1 (sh)
JP (2) JPH0383985A (sh)
KR (2) KR940002826B1 (sh)
CN (1) CN1025031C (sh)
AT (2) ATE104671T1 (sh)
AU (2) AU621238B2 (sh)
CA (2) CA2023018C (sh)
DD (2) DD299428A5 (sh)
DE (2) DE69008275T2 (sh)
DK (1) DK0413516T3 (sh)
ES (2) ES2052179T3 (sh)
FI (1) FI93456C (sh)
HK (1) HK118295A (sh)
HU (2) HU204276B (sh)
IE (1) IE902885A1 (sh)
IL (2) IL95324A (sh)
IN (1) IN170979B (sh)
IS (1) IS3612A7 (sh)
MY (1) MY107240A (sh)
NO (1) NO903511L (sh)
NZ (2) NZ234843A (sh)
PL (2) PL163899B1 (sh)
SG (1) SG59864G (sh)
YU (2) YU150489A (sh)
ZA (3) ZA906300B (sh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3752062T2 (de) * 1986-12-17 1997-09-11 Glaxo Group Ltd Verwendung von heterozyklischen Derivaten zur Herstellung von Arzneimitteln
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
GB9206989D0 (en) * 1992-03-31 1992-05-13 Glaxo Group Ltd Chemical compounds
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!
US6100256A (en) * 1996-12-02 2000-08-08 Merck Sharp & Dohme Ltd. Use of NK-1 receptors antagonists for treating schizophrenic disorders
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101770D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
KR20030087248A (ko) * 2002-05-08 2003-11-14 (주)씨엔아이 온라인을 통한 상거래 기초항목의 설정기능을 갖는 상거래관리장치
US8921555B2 (en) * 2009-06-16 2014-12-30 Merck Sharp & Dohme Corp. Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
GB201416352D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (sh) * 1964-04-22
CH601304A5 (sh) * 1974-02-12 1978-07-14 Buskine Sa
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
HU204530B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ATE104671T1 (de) 1994-05-15
MY107240A (en) 1995-10-31
AU6080390A (en) 1991-02-14
KR910004630A (ko) 1991-03-29
IL95325A (en) 1994-06-24
ES2052179T3 (es) 1994-07-01
DD299428A5 (de) 1992-04-16
CN1049349A (zh) 1991-02-20
ZA906304B (en) 1991-06-26
DE69008275D1 (de) 1994-05-26
EP0412821B1 (en) 1994-11-09
JPH0383985A (ja) 1991-04-09
HUT59375A (en) 1992-05-28
IE902885A1 (en) 1991-02-27
DD299431A5 (de) 1992-04-16
KR910004631A (ko) 1991-03-29
IL95324A0 (en) 1991-06-30
ES2063923T3 (es) 1995-01-16
ZA906300B (en) 1991-05-29
AU621238B2 (en) 1992-03-05
KR940002826B1 (ko) 1994-04-04
ATE113951T1 (de) 1994-11-15
CA2023018A1 (en) 1991-02-11
AU621771B2 (en) 1992-03-19
PL163899B1 (pl) 1994-05-31
DE69014008T2 (de) 1995-03-23
IN170979B (sh) 1992-06-27
US5132309A (en) 1992-07-21
ZA906299B (en) 1991-06-26
FI93456B (fi) 1994-12-30
HK118295A (en) 1995-07-28
HU206677B (en) 1992-12-28
JPH0381277A (ja) 1991-04-05
IL95325A0 (en) 1991-06-30
EP0413516A3 (en) 1991-11-27
DE69014008D1 (de) 1994-12-15
CA2023018C (en) 1995-11-28
NO903511L (no) 1991-02-11
HU204276B (en) 1991-12-30
NZ234843A (en) 1992-03-26
YU154090A (sh) 1992-12-21
NO903511D0 (no) 1990-08-09
PL286443A1 (en) 1992-01-13
FI903974A0 (fi) 1990-08-10
DK0413516T3 (da) 1994-05-24
YU150489A (sh) 1992-12-21
KR940000830B1 (ko) 1994-02-02
US5132303A (en) 1992-07-21
EP0412821A3 (en) 1991-11-27
IL95324A (en) 1994-02-27
EP0413516A2 (en) 1991-02-20
HUT55785A (en) 1991-06-28
DE69008275T2 (de) 1994-08-04
NZ234846A (en) 1992-03-26
CA2023015A1 (en) 1991-02-11
AU6080490A (en) 1991-02-14
CN1025031C (zh) 1994-06-15
PL291648A1 (en) 1992-06-01
EP0413516B1 (en) 1994-04-20
EP0412821A2 (en) 1991-02-13
HU903233D0 (en) 1990-10-28
FI93456C (fi) 1995-04-10
IS3612A7 (is) 1991-02-11
PL164662B1 (pl) 1994-09-30

Similar Documents

Publication Publication Date Title
SG59864G (en) 1-oxa-2-oxo-3,8-diazaspirol[4,5] decane derivatives pharmaceutical compositions containing them and processes for preparing them
CA2160966A1 (fr) Derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE3870338D1 (de) Dhp-manteltablette.
AU9122691A (en) 1-(4-acylaminophenyl)-7,8-methylenedioxy-5h-2,3-benzo-diazep ine derivatives and acid addition salts thereof, pharmaceutical compositions containing them and process for preparing same
CA2153195A1 (fr) Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HU0002288D0 (en) New compounds of 7-oxo-2,3,7,14-tetrahydro-1h-benzo[b]pyrano[3,2-4]acridin carboxylate, a process for their preparation and pharmaceutical compositions containing them
ES8601141A1 (es) Un procedimiento para la produccion de derivados de isoquinolina sustituidos
PT82812A (en) Process for the preparation of new para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylaminopropanol-2-s having beta receptor blocking properties and of pharmaceutical compositions containing the same
IL115028A (en) Cyclohexadiene derivatives their preparation and pharmaceutical compositions containing them
HUT64940A (en) Tetrahydro-naphtaline derivatives and methods for producing these compounds and for preparing pharmaceutical preparatives containing them
HUT61293A (en) Process for producing 6-member heteroaromatic compounds comprising 1-3 nitrogen atoms and pharmaceutical compositions comprising same